BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8452667)

  • 1. Glucocorticoids, lipocortins and the immune response.
    Goulding NJ; Guyre PM
    Curr Opin Immunol; 1993 Feb; 5(1):108-13. PubMed ID: 8452667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.
    Buckingham JC
    Br J Pharmacol; 1996 May; 118(1):1-19. PubMed ID: 8733570
    [No Abstract]   [Full Text] [Related]  

  • 3. Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspects.
    John CD; Gavins FN; Buss NA; Cover PO; Buckingham JC
    Curr Opin Pharmacol; 2008 Dec; 8(6):765-76. PubMed ID: 18845272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis.
    Buckingham JC; Flower RJ
    Mol Med Today; 1997 Jul; 3(7):296-302. PubMed ID: 9257297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids in rheumatoid arthritis--mediators and mechanisms.
    Morand EF; Goulding NJ
    Br J Rheumatol; 1993 Sep; 32(9):816-9. PubMed ID: 8369893
    [No Abstract]   [Full Text] [Related]  

  • 6. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.
    Perretti M; D'Acquisto F
    Nat Rev Immunol; 2009 Jan; 9(1):62-70. PubMed ID: 19104500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system.
    Buckingham JC; Solito E; John C; Tierney T; Taylor A; Flower R; Christian H; Morris J
    Cell Biochem Funct; 2003 Sep; 21(3):217-21. PubMed ID: 12910473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release?
    Loxley HD; Cowell AM; Flower RJ; Buckingham JC
    Neuroendocrinology; 1993 May; 57(5):801-14. PubMed ID: 8413817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocortin-1: cellular mechanisms and clinical relevance.
    Flower RJ; Rothwell NJ
    Trends Pharmacol Sci; 1994 Mar; 15(3):71-6. PubMed ID: 8184489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo.
    Peers SH; Smillie F; Elderfield AJ; Flower RJ
    Br J Pharmacol; 1993 Jan; 108(1):66-72. PubMed ID: 8428216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lipocortin 1 (LC1) in the steroid feedback control of hypothalamo-pituitary-adrenocortical function. In vivo studies.
    Taylor AD; Loxley HD; Flower RJ; Buckingham JC
    Ann N Y Acad Sci; 1994 Nov; 746():446-8. PubMed ID: 7825911
    [No Abstract]   [Full Text] [Related]  

  • 12. Annexin I is a local mediator in neural-endocrine feedback control of inflammation.
    Green PG; Strausbaugh HJ; Levine JD
    J Neurophysiol; 1998 Dec; 80(6):3120-6. PubMed ID: 9862910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid effects on secretion from subsets of lactotrophs: role of folliculo-stellate cells and annexin 1.
    Morris JF; Christian HC; Chapman LP; Epton MJ; Buckingham JC; Ozawa H; Nishi M; Kawata M
    Arch Physiol Biochem; 2002 Apr; 110(1-2):54-61. PubMed ID: 11935401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin 1: the new face of an old molecule.
    Lim LH; Pervaiz S
    FASEB J; 2007 Apr; 21(4):968-75. PubMed ID: 17215481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocortin 1: glucocorticoids caught in the act?
    Smith SF
    Thorax; 1996 Oct; 51(10):1057-9. PubMed ID: 8977609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and the genesis of depressive illness.
    Mitchell AJ
    Br J Psychiatry; 1994 Jun; 164(6):853-4. PubMed ID: 7953008
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroendocrine factors in susceptibility to inflammatory disease: focus on the hypothalamic-pituitary-adrenal axis.
    Sternberg EM
    Horm Res; 1995; 43(4):159-61. PubMed ID: 7750921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress.
    Kapcala LP; Chautard T; Eskay RL
    Ann N Y Acad Sci; 1995 Dec; 771():419-37. PubMed ID: 8597419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions.
    Schöbitz B; Reul JM; Holsboer F
    Crit Rev Neurobiol; 1994; 8(4):263-91. PubMed ID: 7850874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the HPA axis by immune insults: roles and interactions of cytokines, eicosanoids, glucocorticoids.
    Buckingham JC; Loxley HD; Christian HC; Philip JG
    Pharmacol Biochem Behav; 1996 May; 54(1):285-98. PubMed ID: 8728570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.